Abstract:Objective To investigate the incidence, risk factors and outcome of tachycardia-induced cardiomyopathy (TCM) in patients with focal atrial tachycardia (AT). Methods Formal reports for all patients undergoing electrophysiological studies from March 2007 to March 2015 were included, only 196 patients were diagnosed as focal AT. Of the 196 patients, 17 patients (8.67%) were identified to have TCM. Results The TCM patients were mostly young males (P < 0.05). The TCM was more likely to be persistent (P < 0.05). There was no significant difference in tachycardia cycle length or heart rate between the patients with TCM and those with focal AT (P < 0.05). In a multivariable analysis, the younger age and persistent nature were the independent risk factors for TCM. Only the age was significantly different between the TCM patients and non-TCM patients (P < 0.05). In a (51 ± 19)-month follow-up, 16 TCM patients had improved left ventricle ejection fraction after radiofrequency ablation or strict control with Amiodarone (P < 0.05). However, 1 patient died of heart failure due to unauthorized withdrawal of Amiodarone. Conclusions The incidence of TCM is 8.67% in focal AT patients. Younger age and persistent nature are the independent risk factors for TCM. The prognosis of most TCM patients is good.